NasdaqCM - Delayed Quote USD
PDS Biotechnology Corporation (PDSB)
1.6900
+0.1300
+(8.33%)
At close: June 6 at 4:00:00 PM EDT
1.6800
-0.01
(-0.59%)
After hours: June 6 at 7:55:15 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.41M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FREITAG GREGORY GENE Director | Purchase at price 1.33 per share. | Direct | 20,030 | Feb 28, 2025 |
| GLOVER STEPHEN C Director | Purchase at price 1.33 per share. | Direct | 20,031 | Feb 28, 2025 |
Related Tickers
MREO Mereo BioPharma Group plc
2.7400
+11.38%
DAWN Day One Biopharmaceuticals, Inc.
7.19
+3.45%
ACTU Actuate Therapeutics, Inc. Common stock
8.96
-1.43%
LPTX Leap Therapeutics, Inc.
0.3930
-0.56%
CRVS Corvus Pharmaceuticals, Inc.
3.9100
0.00%
XFOR X4 Pharmaceuticals, Inc.
4.3000
+16.22%
TRVI Trevi Therapeutics, Inc.
7.06
+4.75%
NKTR Nektar Therapeutics
0.6660
-1.30%
XLO Xilio Therapeutics, Inc.
0.7000
+3.20%
MRUS Merus N.V.
56.21
+0.36%